 | • レポートコード：MRC2303G140 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥665,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,225,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の市場調査書によると、世界のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模が、予測期間中、CAGR 5.5％で増加すると推測されています。本書では、アクチグラフィセンサー・ポリソムノグラフィー（PSG）装置の世界市場について広く調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（アクチグラフィセンサー、ポリソムノグラフィー（PSG）装置）分析、技術種類別（USB、無線技術、GPS、その他）分析、流通チャネル別（病院、薬局、診断研究室、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などの項目について記載しています。並びに、本書に記載されている企業情報には、ActiGraph LLC、Activinsights Ltd、Aetna Inc.、BMC Medical Co. Ltd、Cidelec、Cleveland Medical Devices Inc.、Compumedics Ltd、Fitbit LLCなどが含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模：製品種類別 - アクチグラフィセンサーの市場規模 - ポリソムノグラフィー（PSG）装置の市場規模 ・世界のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模：技術種類別 - USB技術における市場規模 - 無線技術における市場規模 - GPS技術における市場規模 - その他技術における市場規模 ・世界のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模：流通チャネル別 - 病院チャネルの市場規模 - 薬局チャネルの市場規模 - 診断研究室チャネルの市場規模 - その他チャネルの市場規模 ・世界のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模：地域別 - 北米のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 アメリカのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 カナダのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 メキシコのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 … - ヨーロッパのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 ドイツのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 イギリスのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 フランスのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 … - アジア太平洋のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 中国のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 日本のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 インドのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 … - 南米/中東のアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 ブラジルのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 アルゼンチンのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 サウジアラビアのアクチグラフィセンサー・ポリソムノグラフィー（PSG）装置市場規模 ・競争状況 ・市場機会・将来動向 |
The actigraphy sensors and polysomnography devices market is expected to register a CAGR of 5.5% over the forecast period.
The COVID-19 pandemic has catalyzed rapid technologic disruption in sleep medicine by accelerating consumer demand for products, including recent care delivery changes, telehealth expansion, remote testing, data monitoring, self-monitoring physiological data using pulse oximeters or EEG sensors in consumer-grade rings, watches, eye or headbands, and other wearables, and AI/ML/DL integrations such as those using heart rate variability (HRV). As telemedicine expands, both physicians and patients are becoming more interested in remote diagnostic and data monitoring technology, including the increased use of disposable home sleep apnea testing devices in the context of the pandemic. For instance, the International Journal of Environmental Research and Public Health published an article in January 2021 where the Valence Aware Dictionary and sEntiment Reasoner (VADER), an AI sentiment analysis tool, was enabled for the examination of tweets from pregnant women and discovered anxiety, depressive symptoms, sleep issues, and anguish connected to isolation during the COVID-19 pandemic. The American Academy of Sleep Medicine (AASM)’s Technology Report published in April 2022 projected a 16.6% growth in end-user spending on wearable wristbands and smartwatch devices worldwide between 2021 and 2022 and a 14.6% rise between 2020 and 2021.
Several factors, such as a rise in the geriatric population, the rising incidence of sleep disorders such as insomnia, restless leg syndrome, sleep-related breathing disorders, and chronic sleep disorders like narcolepsy and hypersomnia, especially among adults, and an increase in the research and development for technological advancements in terms of sleep disease diagnostics and management is projected to drive the growth of the market. Several studies published by the National Library of Medicine in 2021 estimated obstructive sleep apnea (OSA) affects 2-9% of the adult population, restless leg syndrome affects 5-10% of adults and 2-4% of children, and narcolepsy affects between 135,000 and 200,000 people in the United States annually.
As a result, most treatment regimens now incorporate actigraphy sensors and polysomnography devices into their clinical treatment plans. In addition, new product launches and technological advancements by major players in the market are positively affecting the growth of the studied market. For instance, the Nature and Science of Sleep published a research in November 2022 stating that the novel deep-learning technique, OSAnet, could be feasible for the detection and identification of obstructive sleep apnea in home-based devices. The algorithm is based on sleep sounds recorded by a non-contact voice recorder that can be used for the assessment and screening of OSA.
Therefore, owing to the aforementioned factors, such as the adoption of advancing digital technologies, remote sleep technologies, and rising sleep-related disorders coupled with the latest product launches, the studied market is expected to grow significantly during the study period. However, stringent regulatory frameworks and standards associated with manufacturing strategies for actigraphy sensors and polysomnography devices are expected to hinder the growth of the market during the study period.
Actigraphy Sensors & Polysomnography Devices Market Trends
Wireless Technology is Expected to Hold Significant Share Over the Forecast Period
- The market is predicted to be dominated by the wireless technology segment since demand is anticipated to be driven by the majority of new products’ technological capabilities, user-friendliness, ability to deliver real-time results, capacity for highly sensitive tests, and ongoing technical improvement in wireless technologies, that are helpful in disease diagnosis. Furthermore, the market for actigraphy sensors and polysomnography devices is to see attractive sales prospects due to the growing adoption of wireless medical equipment and diagnostic tools in the healthcare system of developing countries.
- The manufacturers in the actigraphy sensors and polysomnography devices market are integrating next-generation technologies, such as wireless technologies, in order to increase the accuracy and reliability of their products and ultimately to maintain a strong position in the actigraphy sensors and polysomnography devices market. Furthermore, continuous product launches by major players in the market are positively affecting the growth of the segment. For instance, in September 2022, Amazon announced the launch of a new sleep tracking product to the line, The Halo Rise, which uses contactless sensors to detect sleep quality and states, coupled with movements and breathing patterns. In addition, the Artificial Intelligence in Sleep Medicine Committee of AASM in April 2022 reported that the ubiquitous availability of Photoplethysmography technology in smartwatches and fitness trackers might allow for obstructive sleep apnea diagnosis at scale.
- Thus, the launch of the next-generation actigraphy sensor and polysomnography devices, as well as the majority of manufacturers focusing on deploying wireless technology in their products, are expected to contribute to the segment’s growth over the coming years.
North America is Expected to Dominate the Actigraphy Sensors and Polysomnography Devices Market
- North America is expected to hold a significant share of the global actigraphy sensors and polysomnography devices market during the next five years. The major factors attributing to the growth are the rising geriatric population, the high prevalence of chronic sleep disorders, the efficiency and affordability of the industry with the technological breakthroughs, as well as the presence of established research institutions.
- The rising demand for these devices during COVID-19 to support geriatric patients who experience sleep difficulties, as well as the fact that life expectancy is continuing to increase, is likely to drive the growth of the studied market in this region.
- According to the Department of Veterans Affairs/Department of Defense Health Affairs, the American College of Physicians, and the AASM conclusion in July 2022, up to 66% of people talk in their sleep at some point in their lives, and more than 40% of people with insomnia are believed to also be affected by a mental health disorder in the United States. This increases the demand for devices used to evaluate sleep-related disorders and is expected to drive the growth of actigraphy sensors and polysomnography devices in the region.
- Additionally, the major device manufacturers have been bolstering their distribution and supply chains in the United States since consumer demand for a product is directly correlated with its availability, which results in a bigger market share. For instance, in February 2021, the FDA authorized the marketing of a new prescription device to reduce snoring and mild obstructive sleep apnea in the United States. The eXciteOSA, developed by Signifier Medical Technologies, is the first device that uses neuromuscular stimulation therapy on the tongue while awake through a mouthpiece. In August 2022, AASM launched a two-year pilot program called the AI/Autoscoring Certification Program in order to objectively validate the effectiveness of these auto-scoring systems, which will start accepting applications in early 2023 for polysomnograms for sleep stage scoring.
Actigraphy Sensors & Polysomnography Devices Market Competitor Analysis
The actigraphy sensors and polysomnography devices market is moderately consolidated and competitive and consists of several major players. Some of the companies that are currently dominating the actigraphy sensors and polysomnography devices market are ActiGraph LLC, Activinsights Ltd, Aetna Inc., BMC Medical Co. Ltd, Cidelec, Cleveland Medical Devices Inc., Compumedics Ltd, Fitbit Inc., Garmin Ltd, iHealth Labs Inc., Koninklijke Philips NV, Natus Medical Inc., Nox Medical, ResMed Inc., and SOMNOmedics GmbH, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases and Neurological Disorders
4.2.2 Rise in Demand for Insomnia Treatment and Growing Investments
4.2.3 Emergence of Advanced Technologies to Increase Accessibility of Smart Actigraphy Sensor and PSG Devices
4.3 Market Restraints
4.3.1 Standards and Stringent Regulatory Framework for Manufacturing Strategies
4.4 Industry Attractiveness – Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product Type
5.1.1 Actigraphy Sensors
5.1.1.1 Wrist and Handband Actigraphy Products
5.1.1.2 Wearable Actigraphy Products
5.1.2 Polysomnography Devices
5.1.2.1 Fixed Polysomnography Products
5.1.2.2 Portable Polysomnography Products
5.2 By Technology Type
5.2.1 USB
5.2.2 Wireless Technology
5.2.3 GPS
5.2.4 Others
5.3 By Distribution Channel
5.3.1 Hospitals
5.3.2 Pharmacies
5.3.3 Diagnostic Laboratories
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ActiGraph LLC
6.1.2 Activinsights Ltd
6.1.3 Aetna Inc.
6.1.4 BMC Medical Co. Ltd
6.1.5 Cidelec
6.1.6 Cleveland Medical Devices Inc.
6.1.7 Compumedics Ltd
6.1.8 Fitbit LLC
6.1.9 Garmin Ltd
6.1.10 iHealth Labs Inc.
6.1.11 Koninklijke Philips NV
6.1.12 Nox Medical
6.1.13 ResMed Inc.
6.1.14 SOMNOmedics GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS